Sarcoma Metabolomics: Current Horizons and Future Perspectives

被引:9
|
作者
Esperanca-Martins, Miguel [1 ,2 ,3 ]
Fernandes, Isabel [1 ,3 ,4 ]
Soares do Brito, Joaquim [4 ,5 ]
Macedo, Daniela [6 ]
Vasques, Hugo [4 ,7 ]
Serafim, Teresa [2 ]
Costa, Luis [1 ,3 ,4 ]
Dias, Sergio [2 ,4 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Med Oncol Dept, P-1649028 Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Vasc Biol & Canc Microenvironm Lab, P-1649028 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Translat Oncobiol Lab, P-1649028 Lisbon, Portugal
[4] Univ Lisbon, Fac Med, P-1649028 Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Orthoped & Traumatol Dept, P-1649028 Lisbon, Portugal
[6] Hosp Lusiadas Lisboa, Med Oncol Dept, P-1500458 Lisbon, Portugal
[7] Inst Portugues Oncol Francisco Gentil, Gen Surg Dept, P-1099023 Lisbon, Portugal
关键词
sarcoma; soft tissue sarcoma; bone sarcoma; gastrointestinal stromal tumor; metabolomics; metabolism; SOFT-TISSUE SARCOMA; IN-VITRO; CELL-LINES; CANCER; OSTEOSARCOMA; TUMORS; METABOLISM; INHIBITORS; HALLMARKS; PATHWAY;
D O I
10.3390/cells10061432
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The vast array of metabolic adaptations that cancer cells are capable of assuming, not only support their biosynthetic activity, but also fulfill their bioenergetic demands and keep their intracellular reduction-oxidation (redox) balance. Spotlight has recently been placed on the energy metabolism reprogramming strategies employed by cancer cells to proliferate. Knowledge regarding soft tissue and bone sarcomas metabolome is relatively sparse. Further characterization of sarcoma metabolic landscape may pave the way for diagnostic refinement and new therapeutic target identification, with benefit to sarcoma patients. This review covers the state-of-the-art knowledge on cancer metabolomics and explores in detail the most recent evidence on soft tissue and bone sarcoma metabolomics.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Metabolomics: Current technologies and future trends
    Hollywood, Katherine
    Brison, Daniel R.
    Goodacre, Royston
    PROTEOMICS, 2006, 6 (17) : 4716 - 4723
  • [32] Environmental metabolomics: a critical review and future perspectives
    Bundy, Jacob G.
    Davey, Matthew P.
    Viant, Mark R.
    METABOLOMICS, 2009, 5 (01) : 3 - 21
  • [33] Metabolomics in endometriosis: challenges and perspectives for future studies
    Ortiz, Camila N.
    Torres-Reveron, Annelyn
    Appleyard, Caroline B.
    REPRODUCTION AND FERTILITY, 2021, 2 (02): : R35 - R50
  • [34] Environmental metabolomics: a critical review and future perspectives
    Jacob G. Bundy
    Matthew P. Davey
    Mark R. Viant
    Metabolomics, 2009, 5
  • [35] Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: Current hurdles and future perspectives
    Fleuren, Emmy D. G.
    Versleijen-Jonkers, Yvonne M. H.
    Boerman, Otto C.
    Van der Graaf, Winette Ta.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02): : 266 - 276
  • [36] Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
    Merlini, Alessandra
    Pavese, Valeria
    Manessi, Giulia
    Rabino, Martina
    Tolomeo, Francesco
    Aliberti, Sandra
    D'Ambrosio, Lorenzo
    Grignani, Giovanni
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] CURRENT AND FUTURE HORIZONS IN LARYNGEAL AND VOICE RESEARCH
    WARD, PH
    HANSON, DG
    GERRATT, BR
    BERKE, GS
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (02): : 145 - 152
  • [38] Hepatocellular carcinoma: current state and future horizons
    Akce, Mehmet
    Maithel, Shishir K.
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (01)
  • [39] Immunotherapeutic strategies for sarcoma: current perspectives
    Li, Xueyao
    Wang, Gangyang
    Cai, Zhengdong
    Sun, Wei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (12): : 7693 - 7701
  • [40] Metabolomics in Breast Cancer: Current Status and Perspectives
    Hart, Christopher D.
    Tenori, Leonardo
    Luchinat, Claudio
    Di Leo, Angelo
    NOVEL BIOMARKERS IN THE CONTINUUM OF BREAST CANCER, 2016, 882 : 217 - 234